Switzerland Biotechnology & Medical Research

Veraxa Biotech AG (VRXA)

Track

Track

Veraxa Biotech AG recorded a single insider purchase of 6,024 shares by Warren Hosseinion on September 10, 2026, totaling $10,060.08. This acquisition occurred amidst a 49.1% decline in stock value over the past ninety days, with the equity currently trading near its fifty-two-week low. No recent earnings report data is available for context.
Ticker: VRXA Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Veraxa Biotech AG. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Ziegler Christoph Samuel Non-Executive Director
Transaction date
Purchase
Price
212.50
Quantity 48,075 +19.9%
Value US$341,380
3.1
Hosseinion Warren Non-Executive Director
Transaction date
Purchase
Price
263.72
Quantity 37,631 -33.2%
Value US$4,979,087
Baumann Oliver Rolf Non-Executive Director
Transaction date
Purchase
Price
273.94
Quantity 68,975 -41.9%
Value US$363,255
Antz Christoph Rudiger Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.53
Quantity 5,000 +inf%
Value US$7,650
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-21 2026-10-20 B Purchase
Ziegler Christoph Samuel
Non-Executive Director
48,075 +19.9%
212.50
US$341,380 		48,075 +19.9% 212.50 US$341,380
2026-09-29 2026-09-10 B Purchase
3.1
Hosseinion Warren
Non-Executive Director
37,631 -33.2%
263.72
US$4,979,087 		37,631 -33.2% 263.72 US$4,979,087
2026-08-31 2026-08-27 B Purchase
Baumann Oliver Rolf
Non-Executive Director
68,975 -41.9%
273.94
US$363,255 		68,975 -41.9% 273.94 US$363,255
2026-08-31 2026-08-27 B Purchase
Antz Christoph Rudiger

Chief Executive Officer

Executive Director
5,000 +inf%
1.53
US$7,650 		5,000 +inf% 1.53 US$7,650
Explore more

More insider trading research around Veraxa Biotech AG

More insider trades in Switzerland
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe